Filament Health Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FLHLF research report →
Price Chart
About the company
Filament Health Corp. is a pioneering company dedicated to the discovery and extraction of natural psychedelic compounds. Its operations encompass the cultivation of psychedelic plants, genetic research, advanced extraction methodologies, and the conduct of internal clinical trials.
- CEO
- Benjamin Lightburn
- IPO
- 2021
- Employees
- 13
- HQ
- Burnaby, BC, CA
Get TickerSpark's AI analysis on FLHLF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $26.18K
- P/E
- -0.50
- PEG
- -0.02
- P/S
- 6.37
- P/B
- 1.36
- EV/EBITDA
- -0.84
- Div Yield
- 0.00%
- Gross Margin
- 65.12%
- Op Margin
- -594.96%
- Net Margin
- -805.93%
- ROE
- -234.50%
- ROIC
- -174.24%
Latest fiscal year · YoY change
- Revenue
- $616.68K-71.1%
- Gross Profit
- $616.68K-71.1%
- Op Income
- $-3,669,276
- Net Income
- $-4,970,272+6.6%
- EPS
- $-0.02+26.4%
- OCF Growth
- +45.3%
- FCF Growth
- +44.9%
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.01
- Beta
- 0.72
- RSI (14)
- 16
- Avg Volume
- 178
No earnings-call transcripts are available for FLHLF yet.
- Free Float
- 51.2%
- Shares Outstanding
- 261.79M
- Float Shares
- 134.12M
Our FLHLF coverage
Recent articles, reports, and earnings notes.
No research on FLHLF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FLHLF report →Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution
newsfilecorp.com · Apr 30
Red Light Holland Announces Filament Health Obtains Final Order for Proposed Arrangement
newsfilecorp.com · Apr 29
Red Light Holland Announces Filament Health Shareholder Approval of Acquisition
newsfilecorp.com · Apr 27
Red Light Holland Announces Filament Health Obtains Interim Order for Proposed Arrangement
newsfilecorp.com · Mar 23
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression
accessnewswire.com · Mar 16
RETRANSMISSION: Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation
newsfilecorp.com · Mar 11
Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation
newsfilecorp.com · Mar 10
Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation (INIA) Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health and CNS Indications of Coca
accessnewswire.com · Jul 8
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.